Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
23%
OVERLAP
BY WEIGHT
42
# OF OVERLAPPING
HOLDINGS
VHT
421
HOLDINGS
11%
ALSO IN CANC
CANC
56
HOLDINGS
75%
ALSO IN VHT
SECTOR DRIFT (VHT minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
| MERCK & CO. INC. | 5.0% | 5.3% | 5.0% | |
| ELI LILLY & CO | 13.1% | 4.7% | 4.7% | |
| ABBVIE INC | 6.8% | 3.6% | 3.6% | |
| JOHNSON & JOHNSON | 8.6% | 2.5% | 2.5% | |
| BRISTOL-MYERS SQUIBB CO | 1.7% | 3.1% | 1.7% | |
VHT Overweight Relative to CANC
| ELI LILLY & CO | 8.4% | |
| JOHNSON & JOHNSON | 6.1% | |
| UNITEDHEALTH GROUP INC | 4.8% | |
| THERMO FISHER SCIENTIFIC INC | 3.4% | |
| ABBVIE INC | 3.1% | |
| ABBOTT LABORATORIES | 2.4% | |
| PFIZER INC | 2.2% | |
| INTUITIVE SURGICAL INC | 2.1% | |
| DANAHER CORP | 1.9% | |
| VERTEX PHARMACEUTICALS INC | 1.8% |
VHT Underweight Relative to CANC
| REVOLUTION MEDICINES, INC. | -5.0% | |
| COGENT BIOSCIENCES INC | -4.7% | |
| NOVARTIS AG | -3.9% | |
| GENMAB A/S SPONSORED ADR | -3.7% | |
| BEIGENE LTD. SPONSORED ADR | -3.5% | |
| IOVANCE BIOTHERAPEUTICS INC | -3.3% | |
| EXELIXIS INC | -3.1% | |
| HALOZYME THERAPEUTICS INC | -3.1% | |
| ROCHE HOLDINGS LTD-SPONS ADR | -2.7% | |
| BRIDGEBIO PHARMA, INC. | -2.6% |